Detalhe da pesquisa
1.
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 403(10429): 813-823, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387470
2.
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
J Infect Dis
; 228(6): 715-722, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202147
3.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Lancet
; 399(10321): 237-248, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953526
4.
Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial.
Clin Infect Dis
; 75(1): e783-e791, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551104
5.
Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials.
Clin Infect Dis
; 74(4): 668-677, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021314
6.
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
PLoS Med
; 19(5): e1003953, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617368
7.
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
J Virol
; 95(4)2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219167
8.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet
; 395(10240): 1845-1854, 2020 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450106
9.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 396(10249): 479-488, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702299
10.
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
J Infect Dis
; 222(5): 746-754, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563194
11.
Human Infection with an Avian-Origin Influenza A (H10N3) Virus.
N Engl J Med
; 386(11): 1087-1088, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294820
12.
Quorum sensing regulation confronts the development of a viable but non-culturable state in Vibrio cholerae.
Environ Microbiol
; 22(10): 4314-4322, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319181
13.
A case-control study on the risk factors for hemorrhagic fever with renal syndrome.
BMC Infect Dis
; 20(1): 103, 2020 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019494
14.
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
J Infect Dis
; 220(10): 1551-1557, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958543
15.
Rapid detection of human mastadenovirus species B by recombinase polymerase amplification assay.
BMC Microbiol
; 19(1): 8, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30621594
16.
Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
Liver Int
; 39(1): 70-80, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025200
17.
Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China.
BMC Infect Dis
; 19(1): 617, 2019 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299910
18.
Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese.
Hum Mol Genet
; 25(6): 1225-32, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26769676
19.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017399
20.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738667